The Ohio State University (OSU) is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Clinical Trials Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
The Ohio State University (OSU) has participated in 12 clinical trials with 5 currently active.
Therapeutic areas: Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma.
Sponsors: Eli Lilly and Company, Incyte Corporation, Mural Oncology, Inc.
Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Ohio State University (OSU) has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Ohio State University (OSU) has 12 clinical trials on record, with 5 currently active. Their work covers Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma.
The Ohio State University (OSU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.